Physician

Marissa Lindsey Wedel, M.D.

According to 2025 Medicare claims, Marissa Wedel, M.D. (NPI: 1649434796) practices ophthalmology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is PENNSYLVANIA RETINA SPECIALISTS PC (NPI: 1568428126; TIN: 232152842) and primary practice location at 17011-1776.

Wedel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 678 traditional Medicare patients, billed 36,944 HCPCS/CPT codes, and received $1,855,776 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 531 prescription claims across 183 beneficiaries totaling $149,191 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 5 records totaling $214. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$928K$1.9M2021 Medicare payment: $53,700 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,217,213 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,429,069 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,855,776 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202159260$53,700
20227277,096$1,217,213
202369816,420$1,429,069
202467836,944$1,855,776

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$75K$149K2022 Drug cost: $26,837 (USD; Tot_Drug_Cst)2023 Drug cost: $88,747 (USD; Tot_Drug_Cst)2024 Drug cost: $149,191 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022118382$26,837
2023156507$88,747
2024183531$149,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system185200$89
67028Injection of drug into eye3291,141$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more357672$67
92134Imaging of retina5001,412$30
92250Photography of the retina294371$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept381,082$98,971
Bromfenac SodiumBromfenac Sodium28497$3,308
DifluprednateDifluprednate34711$3,199
Prednisolone AcetatePrednisolone Acetate691,918$2,343
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1502,915$1,626

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$214Carl Zeiss Meditec USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Marissa Lindsey Wedel, M.D.?

Tedicare shows public-source Medicare data for Marissa Lindsey Wedel, M.D. (NPI 1649434796), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marissa Lindsey Wedel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Marissa Lindsey Wedel, M.D.?

Marissa Lindsey Wedel, M.D. is linked to PENNSYLVANIA RETINA SPECIALISTS PC (billing NPI 1568428126) in the available physician profile data.

Does Marissa Lindsey Wedel, M.D. have Open Payments data?

Marissa Lindsey Wedel, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.